Please assess the completion status of the following clinical trial:

Trial Title: Intra-articular Autologous Bone Marrow Aspirate Injection for Knee Osteoarthritis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* \>=3 months of symptomatic knee OA unresponsive to at least two of the following: activity modification, physical therapy, bracing, assistive devices, acupuncture, non-steroidal anti-inflammatory medications, local steroid injections, and hyaluronic acid injections~* Radiographically confirmed Kellgren-Lawrence I-II knee OA (mild knee OA; no bone-on-bone)~* Age 18-79 years~Exclusion Criteria:~* Presence of loose bodies on baseline magnetic resonance imaging~* Clinically and radiologically confirmed anterior/posterior cruciate ligament deficiences~* History of meniscal injury other than degenerative meniscal tears~* Previous knee surgery~* Presence of a degenerative meniscal tear causing mechanical symptoms such as locking, buckling, or give-way~* Intra-articular injection to affected knee within 6 weeks of intra-articular BMA injection~* Mechanical axis deviation greater than 7 degrees~* Intolerance to acetaminophen or hydrocodone (i.e., Vicodin)~* Use of non-steroidal anti-inflammatory drugs \<1 weeks prior to BMA~* Injection of the joint scheduled for treatment within 3 months of BMA injection~* Body mass index of 30 or more~* History of drug abuse~* Current cigarette smokers~* Current use of systemic steroids~* History of or current alcohol abuse or dependence~* History of anemia, bleeding disorders, or inflammatory joint disease~* Active infection~* Active malignancy per medical or surgical history, diagnosed by primary case physician or treating specialist, undergoing treatment, has undergone treatment, or has declined treatment~* Inability to refrain from statin regimen from 1 month pre-injection to 1 month post-injection~* Pregnancy or breastfeeding at time of treatment~* Participating or planning to participate in a worker's compensation program at the time of treatment or follow-up period~* Pending or planned legal action pertaining to knee pain~* Non-English speaking

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- Bone Marrow Aspirate (BMA) Injection (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).